PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Disease Reportsacne vulgaris
MeSH D000152 - acne vulgaris
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D012625:Sebaceous gland diseases
0 Companies
0 Drugs
Success rate
D017486:Acneiform eruptions
1 Company
2 Drugs
$
Success rate
D000152: 
Acne vulgaris
131 Companies
37 Drugs
$
Success rate
D000069316:Acne conglobata
0 Companies
0 Drugs
Success rate
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
3MHexachlorophene Scrubteam Surgical Spongebrush  1982-01-01   
A.H. Robins CompanyErythromycin lactobionate Erythromycin  1985-03-28   
Erythromycin Robimycin  1982-01-01   
Tetracycline Tetracycline  1982-01-01   
Abbott BiotherapeuticsClindamycin Clindamycin  2001-06-29   
Erythromycin lactobionate Erythrocin  1988-01-04   
Tetracycline Tetracycline  1982-01-01   
AbbVieTazarotene Tazorac  1997-06-13   
Abon PharmaceuticalsErythromycin Erythromycin  2025-09-23   
Alembic PharmaceuticalsAdapalene Adapalene  2020-06-18   
Adapalene, Benzoyl peroxide Adapalene Benzoyl Peroxide  2022-08-04   
Erythromycin Erythromycin  2023-08-24   
Clindamycin Clindamycin  2024-04-02   
Tretinoin Tretinoin  2024-04-29   
Alkem LaboratoriesErythromycin Erythromycin  2022-07-13   
Minocycline Minocycline  2016-09-28   
AllerganTazarotene Avage  2000-09-29   
Ethinyl estradiol, Norethindrone Brevicon  1982-01-01   
Ethinyl estradiol, Norethindrone Estrostep Fe  1996-10-09   
Ethinyl estradiol, Norethindrone Femcon Fe  2003-11-14   
Ethinyl estradiol, Norethindrone Femhrt  1999-10-15   
Ethinyl estradiol, Norethindrone Lo Loestrin Fe 2029-02-02 2010-10-21   
Ethinyl estradiol, Norethindrone Lo Minastrin Fe 2029-02-02 2013-07-24   
Ethinyl estradiol, Norethindrone Minastrin  2013-05-08   
Ethinyl estradiol, Norethindrone Norinyl 1+35  1982-01-01   
Ethinyl estradiol, Norethindrone Taytulla  2013-04-19   
Tretinoin Tretinoin  2010-03-22   
Adapalene Adapalene  2014-10-27   
Adapalene, Benzoyl peroxide Adapalene Benzoyl Peroxide  2015-09-30   
Azelaic acid Azelaic Acid  2018-11-19   
Clindamycin Clindamycin  1988-06-08   
Clindamycin, Benzoyl peroxide Clindamycin Benzoyl Peroxide  2015-06-19   
Clindamycin, Tretinoin Clindamycin Tretinoin  2015-06-12   
Ethinyl estradiol, Desogestrel Desogestrel Ethinyl Estradiol  2005-07-29   
Erythromycin estolate Erythromycin Estolate  1982-01-01   
Erythromycin stearate Erythromycin Stearate  1982-01-01   
Isotretinoin Isotretinoin  2021-03-31   
Minocycline Minocycline  1991-12-30   
Ethinyl estradiol, Norethindrone Norethin  1988-04-12   
Ethinyl estradiol, Norethindrone Norethindrone Ethinyl Estradiol  1987-01-29   
Ethinyl estradiol, Norethindrone Norethindrone Ethinyl Estradiol ()  1991-09-24   
Tetracycline Tetracycline  1982-01-01   
AlmirallAzelaic acid Azelex  1995-09-13   
Sarecycline Seysara 2028-08-10 2018-10-01   
Tretinoin, Mequinol Solage  1999-12-10   
Clindamycin, Tretinoin Veltin  2010-07-16   
AlpharmaErythromycin Erythromycin  1982-04-19   
Erythromycin estolate Erythromycin Estolate  1982-11-18   
Erythromycin Erythromycin Ethylsuccinate  1982-01-01   
Tetracycline Tetracycline  1982-01-01   
1
2
3
4
5
6
...
14
>
Clinical Trials
Historical Success Rate
Phase 1
81%
21/26
Phase 2
52%
22/42
Phase 3
86%
44/51
Approved: 18Overall Success rate: 37%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
3M
Hexachlorophene
Abbott Biotherapeutics
Erythromycin lactobionate
AbbVie
Leuprolide,
Leuprolide acetate,
Norethindrone
Allergan
Clindamycin,
Tetracycline,
Tretinoin,
Azelaic acid,
Tazarotene,
Adapalene,
Norethindrone,
Benzoyl peroxide,
Minocycline,
Enoblituzumab,
Retinol,
Fmx101,
Benoxyl
Almirall
Sarecycline
Amneal Pharmaceuticals
Estradiol,
Estradiol benzoate,
Estradiol valerate
1
2
3
4
5
6
...
9
>
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use